Rehmann Capital Advisory Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $668K | Buy |
|
|||||
|
2025
Q1 | $615K | Buy |
|
|||||
|
2024
Q4 | $535K | Sell |
|
|||||
|
2024
Q3 | $726K | Sell |
|
|||||
|
2024
Q2 | $727K | Sell |
|
|||||
|
2024
Q1 | $681K | Buy |
|
|||||
|
2023
Q4 | $701K | Buy |
|
|||||
|
2023
Q3 | $600K | Buy |
|
|||||
|
2023
Q2 | $309K | Buy |
|
|||||
|
2023
Q1 | $276K | Sell |
|
|||||
|
2022
Q4 | $300K | Sell |
|
|||||
|
2022
Q3 | $269K | Buy |
|
|||||
|
2022
Q2 | $286K | Sell |
|
|||||
|
2022
Q1 | $306K | Buy |
|
|||||
|
2021
Q4 | $297K | Sell |
|
|||||
|
2021
Q3 | $397K | Buy |
|
|||||
|
2021
Q2 | $283K | Sell |
|
|||||
|
2021
Q1 | $280K | Buy |
|
|||||
|
2020
Q4 | $304K | Buy |
|
|||||
|
2020
Q3 | $272K | Sell |
|
|||||
|
2020
Q2 | $277K | Buy |
|
|||||
|
2020
Q1 | $247K | Buy |
|
|||||
|
2019
Q3 | $436K | Sell |
|
|||||
|
2019
Q2 | $483K | Buy |
|
|||||
|
2019
Q1 | $416K | Buy |
|
|||||
|
2018
Q4 | $322K | Buy |
|
|||||
|
2018
Q3 | $137K | Sell |
|
|||||
|
2018
Q2 | $122K | Sell |
|
|||||
|
2018
Q1 | $204K | Buy |
|
|||||
|
2017
Q4 | $211K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $269K | Buy |
|
|||||
|
2016
Q4 | $227K | Sell |
|
|||||
|
2016
Q3 | $310K | Sell |
|
|||||
|
2016
Q2 | $335K | Sell |
|
|||||
|
2016
Q1 | $314K | Sell |
|
|||||
|
2015
Q4 | $401K | Sell |
|
|||||
|
2015
Q3 | $504K | Buy |
|
|||||
|
2015
Q2 | $524K | Buy |
|
|||||
|
2015
Q1 | $483K | Buy |
|
|||||
|
2014
Q4 | $440K | Buy |
|
|||||
|
2014
Q3 | $436K | Buy |
|
|||||
|
2014
Q2 | $417K | Buy |
|
|||||
|
2014
Q1 | $355K | Sell |
|
|||||
|
2013
Q4 | $488K | Sell |
|
|||||
|
2013
Q3 | $472K | Sell |
|
|||||
|
2013
Q2 | $469K | Buy |
|